Выделить слова:


Патент США №	8237010
Автор(ы)	Boehringer и др.
Дата выдачи	07 августа 2012 г.

Method of manufacturing a dressing

РЕФЕРАТ

A therapeutic device for promoting the healing of a wound in a mammal is disclosed. An exemplary device comprises a permeable structure having a plurality of depressions formed in a surface thereof. In use, the surface having the depressions is disposed adjacent a surface of the wound. A method of manufacturing a therapeutic device for promoting the healing of a wound in a mammal comprising the steps of providing a permeable substrate, and forming a plurality of depressions into a surface of the permeable substrate to provide the therapeutic device. A method of treating a wound comprises: providing a permeable structure comprising a plurality of randomly disposed fibers and having i) a plurality of wound surface contact elements disposed between end portions of the structure, and ii) a plurality of voids defined by the contact elements; and applying the permeable structure to at least one surface of the wound.

Авторы:	John R. Boehringer (Wynnewood, PA), John Karpowicz (Chester Springs, PA), Christopher L. Radl (Malvern, PA)
Заявитель:	Boehringer Technologies, L.P. (Phoenixville, PA)
ID семейства патентов	35061520
Номер заявки:	13/221,472
Дата регистрации:	30 августа 2011 г.

Prior Publication Data


	Document Identifier	Publication Date
	US 20120001366 A1	Jan 5, 2012

Отсылочные патентные документы США


Application Number	Filing Date	Patent Number	Issue Date
12469332	May 20, 2009	8022266
10982346	Feb 8, 2011	7884258
60561745	Apr 13, 2004

Класс патентной классификации США:	602/43; 264/5; 424/443; 424/445; 424/446; 424/447; 424/448; 424/449; 425/6; 428/939; 602/42; 602/44; 602/45; 602/46; 602/47; 602/48; 602/58; 602/59; 602/75; 602/76; 75/313
Класс совместной патентной классификации:	A61F 13/00021 (20130101); A61F 13/00063 (20130101); A61F 13/00995 (20130101); A61F 13/0283 (20130101); A61M 1/0088 (20130101); A61F 13/0216 (20130101); A61F 13/00042 (20130101); A61F 2013/0028 (20130101); A61F 2013/00217 (20130101); A61F 2013/00221 (20130101); A61F 2013/00251 (20130101); A61F 2013/00255 (20130101); A61F 2013/00327 (20130101); A61F 2013/00536 (20130101); A61F 2013/0054 (20130101); A61F 2013/00561 (20130101); A61F 2013/00608 (20130101); A61F 2013/00863 (20130101); A61F 2013/0091 (20130101); A61F 2013/00927 (20130101); A61F 2013/00936 (20130101); A61M 27/00 (20130101); Y10S 428/939 (20130101)
Класс международной патентной классификации (МПК):	A61F 13/00 (20060101); B29B 9/00 (20060101); B22D 11/01 (20060101); B22F 9/00 (20060101); B28B 1/54 (20060101); B28B 17/00 (20060101); C21C 7/04 (20060101); C22B 7/04 (20060101); C22B 9/10 (20060101); C22C 1/06 (20060101); A61K 9/70 (20060101); A61L 15/00 (20060101); A61L 15/16 (20060101); C21B 3/02 (20060101); C21B 5/02 (20060101); C21B 7/06 (20060101); C21C 5/02 (20060101)
Область поиска:	;602/42-48,58-59,75-76 ;424/443,445-449 ;75/313 ;264/5 ;428/939 ;425/6

Использованные источники

[Referenced By]

Патентные документы США


2122121	June 1938	Tillotson
2385207	September 1945	Hunn
3042037	July 1962	Scales et al.
3053252	September 1962	Wolf
3568675	March 1971	Harvey
3602220	August 1971	Bunyan
3616156	October 1971	Scholl
3703897	November 1972	Mack et al.
3790433	February 1974	Baron
3874387	April 1975	Barbieri
3929135	December 1975	Thompson
4180074	December 1979	Murry et al.
4224945	September 1980	Cohen
4252590	February 1981	Rasen et al.
4323069	April 1982	Ahr et al.
4382441	May 1983	Svedman
4533352	August 1985	Van Beek et al.
4542739	September 1985	Schafer et al.
4906240	March 1990	Reed et al.
4969880	November 1990	Zamierowski
4997425	March 1991	Shioya et al.
5034006	July 1991	Hosoda et al.
5100396	March 1992	Zamierowski
5147338	September 1992	Lang et al.
5176663	January 1993	Svedman et al.
5261893	November 1993	Zamierowski
5358494	October 1994	Svedman
5409472	April 1995	Rawlings et al.
5437651	August 1995	Todd et al.
5447505	September 1995	Valentine et al.
5527293	June 1996	Zamierowski
5549584	August 1996	Gross
5633007	May 1997	Webb
5636643	June 1997	Argenta et al.
5645081	July 1997	Argenta et al.
5810756	September 1998	Montecalvo
5919180	July 1999	Raimondo
6071267	June 2000	Zamierowski
6126701	October 2000	Calogero
6203563	March 2001	Fernandez
6207875	March 2001	Lindqvist
6345623	February 2002	Heaton et al.
6458109	October 2002	Henley et al.
6520982	February 2003	Boynton et al.
6626891	September 2003	Ohmstede
6663584	December 2003	Griesbach et al.
6682757	January 2004	Wright
6685681	February 2004	Lockwood et al.
6689931	February 2004	Etheredge, III
6695823	February 2004	Lina et al.
6737149	May 2004	Wintermantel et al.
6752794	June 2004	Lockwood et al.
6755807	June 2004	Risk, Jr. et al.
6764462	July 2004	Risk, Jr. et al.
6767334	July 2004	Randolph
6800074	October 2004	Henley et al.
6885135	April 2005	Kanao et al.
6897349	May 2005	Gibbins et al.
6936037	August 2005	Bubb et al.
6951553	October 2005	Bubb et al.
6979324	December 2005	Bybordi et al.
7070584	July 2006	Johnson et al.
7108683	September 2006	Zamierowski
7117869	October 2006	Heaton et al.
7273054	September 2007	Heaton et al.
7338482	March 2008	Lockwood et al.
7381211	June 2008	Zamierowski
7381859	June 2008	Hunt et al.
7385101	June 2008	Chandra
7494482	February 2009	Orgill et al.
7534927	May 2009	Lockwood et al.
2001/0031943	October 2001	Urie
2001/0043943	November 2001	Coffey
2004/0002676	January 2004	Siegwart et al.
2004/0006319	January 2004	Lina et al.
2004/0064111	April 2004	Lockwood et al.
2004/0064132	April 2004	Boehringer et al.
2004/0093026	May 2004	Weidenhagen et al.
2004/0122434	June 2004	Argenta et al.
2004/0127837	July 2004	Sigurjonsson
2005/0064021	March 2005	Rippon et al.
2005/0070858	March 2005	Lockwood et al.
2005/0209574	September 2005	Boehringer et al.
2006/0041247	February 2006	Petrosenko et al.
2006/0064049	March 2006	Marcussen
2006/0128245	June 2006	Muth et al.

Зарубежные патентные документы


0619105	Oct 1994	EP
2329127	Mar 1999	GB
8001139	Jun 1980	WO
9100718	Jan 1991	WO
0045761	Aug 2000	WO
0134079	May 2001	WO
01037922	May 2001	WO
02092783	Nov 2002	WO
03057070	Jul 2003	WO
03057071	Jul 2003	WO
2004037334	May 2004	WO
2005046761	May 2005	WO
2005046762	May 2005	WO

Другие источники

Argenta et al., "Vacuum-Assisted Closure: A New Method for Wound Control and Treatment: Clinical Experience", Annals of Plastic Surgery, vol. 38 (1997), pp. 563-577. cited by other .
E. Karamuk et al., Tissupor: Development of a structured wound dressing based on a textile composite functionalized by embroidery technology, tissupor.sub.--kti.url pubished Sep. 2001, downloaded Oct. 6, 2004, Switzerland. cited by other .
Chariker et al., Effective managment of incisional and cutaneous fistulae with closed suction wound drainage, Contempory Surgery, vol. 34, Jun. 1989, pp. 59-63. cited by other .
Ko; Fabrics, Encyclopedia of Biomaterials and Biomedical Engineering, 2004, Draft Copy, pp. 1-38. cited by other .
MA, Scaffolds for tissue fabrication, Materialstoday, May 2004, pp. 30-40. cited by other .
Marois et al., Endothlial Cell Behavior on Vascular Prosthetic Grafts: Effect of Polymer Chemistry, Surface Structure, and Surface Treatment, ASAIO Journal 1999, pp. 272-280. cited by other .
Saxena et al., Vacuum-Assisted Closure: Microdeformations of Wounds and Cell Proliferation, Plastic and Reconstructive Surgery, Oct. 2004, vol. 114, No. 5, pp. 1086-1096. cited by other .
Schein et al., The `sandwich technique` in the management of the open abdomen, Br. J. Surgery, May 1986, vol. 73, No. 5, pp. 369-370. cited by other .
Svedman et al., A Dressing System Provding Fluid Supply and Suction Drainage Used for Continuous and Intermittent Irrigation, Annals of Plastic Surgery, Aug. 1996, vol. 17, No. 2, pp. 125-132. cited by other .
Wiliams, Benefit and risk in tissue engineering, Materialstoday, May 2004, pp. 24-29. cited by other .
International Search Report dated Jun. 20, 2006 regarding International Application No. PCT/US05/08129. cited by other.

Главный эксперт: Bianco; Patricia
Assistant Examiner: Jackson; Brandon L
Уполномоченный, доверенный или фирма: Caesar, Rivise, Bernstein, Cohen & Pokotilow, Ltd.

ФОРМУЛА ИЗОБРЕТЕНИЯ

What is claimed is:

1. A method of manufacturing a therapeutic device for promoting the healing of a wound in a mammal comprising the steps of: providing a molten substrate material; providing a mold defining a plurality of depressions and a plurality of contact elements; applying the molten substrate material to the mold; cooling the molten substrate material to form the therapeutic device in the mold; and removing the therapeutic device from the mold, wherein the therapeutic device is a permeable structure comprising: a first surface adapted to be disposed in contact with the wound, a second surface adapted to establish a confined space when covered with a cover, a plurality of interstices located between the first surface and the second surface, and a plurality of discrete voids in the first surface in communication with at least some of the interstices, wherein the voids are resistant to collapse in a force range from 0.1 to 5.0 psi to maintain at least some empty space therein when the therapeutic device is subjected to a compressive force of suction, such that tissue at the voids adopts a catenary shape that encourages cellular activity and facilitates wound healing.

2. A method of manufacturing a therapeutic device for promoting the healing of a wound in a mammal comprising the steps of: providing a permeable substrate; and forming a plurality of depressions into a surface of the permeable substrate to provide the therapeutic device, wherein the therapeutic device is a dressing comprising: a first surface adapted to be disposed in contact with a wound, a second surface adapted to establish a confined space when covered with a cover, a plurality of interstices located between the first surface and the second surface, and a plurality of discrete voids in the first surface in communication with at least some of the interstices, wherein the voids are resistant to collapse in a force range from 0.1 to 5.0 psi to maintain at least some empty space therein when the therapeutic device is subjected to a compressive force of suction, such that tissue at the voids adopts a catenary shape that encourages cellular activity and facilitates wound healing.

3. The method of claim 2 wherein the step of forming the plurality of depressions comprises heat stamping.

4. The method of claim 2 wherein the step of forming the plurality of depressions comprises vacuum forming.

5. The method of claim 2 wherein the step of forming the plurality of depressions comprises embossing.

6. The method of claim 2 wherein the step of forming the plurality of depressions comprises cutting.

7. The method of claim 2 wherein the step of forming the plurality of depressions comprises delivering convective heat across at least one surface of the structure at approximately the melting temperature of the structure material.

ОПИСАНИЕ

ОБЛАСТЬ ТЕХНИКИ, К КОТОРОЙ ОТНОСИТСЯ ИЗОБРЕТЕНИЕ

The invention relates to a device and method for treating wounds. More specifically, the present invention relates to a therapeutic wound contact device.

ПРЕДПОСЫЛКИ СОЗДАНИЯ ИЗОБРЕТЕНИЯ

Wound healing is a basic reparative process of the human body. It has been known throughout time that dressing wounds with appropriate materials aids the body's natural regenerative process. Historically, such materials have been made from cotton fibers; e.g. gauze. These dressings are beneficial to the healing process because they insulate damaged tissue from external contaminants and because they remove potentially deleterious wound exudates.

Numerous studies suggest that wound healing depends on the interplay of complex mechanisms involving cell proliferation, migration and adhesion coupled with angiogenesis. Application of traditional gauze or other essentially flat materials are essentially sub-optimal with respect to these mechanisms. Wound healing studies In-vitro carried out in cell culture vehicles that permit cellular function. It is therefore desirable in the practice of wound healing to provide the equivalent of cell culture or a bioreactor system to allow the optimal interplay of cell functions of proliferation, migration and adhesion. Additionally, it is essential to incorporate other bodily functions that encourage the supply of fibronectins, plasma proteins, oxygen, platelets, growth factors, immunochemicals and so forth.

As science and medicine have advanced, the technology incorporated into wound healing devices has improved substantially. Highly absorbent wound dressings capable of absorbing many times their weight in liquids are available. Systems that temporarily seal wounds and utilize suction to remove exudates have found widespread utilization. Dressings incorporating anti-microbial agents and biologic healing agents are common. Devices that provide a moist wound environment for improved healing have been found to be useful.

In spite of the technological gains in wound healing devices and dressings, millions of people still suffer from the chronic wounds. Such chronic wounds are debilitating and can last for years, greatly diminishing the individual's quality of life. Often such wounds result in the loss of a limb. Individuals may even die from complications such as infection.

As such, there is dire need for more effective wound healing devices and methods.

СУЩНОСТЬ ИЗОБРЕТЕНИЯ

To provide for improved wound healing, the present invention is a wound contact material, a method for making the wound contact material, and a method of treatment employing the wound contact material.

According to an exemplary embodiment of the present invention, a therapeutic device for promoting the healing of a wound in a mammal is provided. The device comprises a permeable substrate or structure having a plurality of depressions formed in a surface thereof, wherein said surface having said depressions is disposed in surface contact with the wound.

According to a further exemplary embodiment of the present invention, a therapeutic device for promoting the healing of a wound in a mammal is provided. The device comprises a permeable structure having a plurality of wound surface contact elements disposed between end portions of the structure, and a plurality of voids defined by the contact elements.

According to an additional exemplary embodiment of the present invention, a therapeutic device for promoting the healing of a wound in a mammal, the device comprising a permeable structure comprising a plurality of fibers coupled to one another having a plurality of wound surface contact elements disposed between end portions of the structure and a plurality of voids defined by the contact elements is provided.

According to a yet further exemplary embodiment of the present invention, a therapeutic device for promoting the healing of a wound in a mammal, the device comprising a polyester felt having a plurality of wound surface contact elements disposed between end portions of the structure and a plurality of voids defined by the contact elements is provided.

According to an additional exemplary embodiment of the present invention, a method of manufacturing a therapeutic device for promoting the healing of a wound in a mammal comprises the steps of providing a molten substrate material providing a mold defining a plurality of depressions and a plurality of contact elements and applying the molten substrate material to the mold.

According to an even further exemplary embodiment of the present invention, a method of manufacturing a therapeutic device for promoting the healing of a wound in a mammal comprises the steps of providing a permeable structure and forming a plurality of depressions into a surface of the permeable structure.

According to another exemplary embodiment of the present invention, a method of treating a wound comprises the steps of providing a permeable structure comprising i) a plurality of wound surface contact elements disposed between end portions of the structure, and ii) a plurality of voids defined by the contact elements, and applying the permeable structure to at least one surface of the wound and applying a force to the structure to maintain the structure in intimate contact with the wound surface.

These and other aspects and objects will become apparent from the following description.

КРАТКОЕ ОПИСАНИЕ РИСУНКОВ

The invention is best understood from the following detailed description when read in connection with the accompanying drawings. It is emphasized that, according to common practice, the various features of the drawings are not to scale. On the contrary, the dimensions of the various features are arbitrarily expanded or reduced for clarity. Included in the drawings are the following Figures:

FIG. 1 is a perspective view of a channeled wound contact dressing according to a first exemplary embodiment of the present invention;

FIG. 2A is a perspective view of a channeled wound contact composite according to a second exemplary embodiment of the present invention;

FIG. 2B is a cross section of the channeled wound contact composite according to the second exemplary embodiment of FIG. 2A;

FIG. 3A is a perspective view of a dimpled wound dressing according to a third exemplary embodiment of the present invention;

FIG. 3B is a top view of the dimpled wound dressing illustrated in FIG. 3A;

FIG. 3C is a bottom view of the dimpled wound dressing illustrated in FIG. 3A;

FIG. 3D is a cross sectional view of the dimpled wound dressing illustrated in FIG. 3A;

FIGS. 4A, 4B and 4C are illustrations of the dimpled wound dressing of FIG. 3A in use;

FIG. 5A is a perspective view of an irregular wound contact dressing according to a fourth exemplary embodiment of the present invention;

FIG. 5B is a cross sectional view of the irregular wound contact dressing illustrated in FIG. 5A; and

FIG. 6 is a cross sectional view of an exemplary wound contact device in use on a wound.

ПОДРОБНОЕ ОПИСАНИЕ ИЗОБРЕТЕНИЯ

A wound dressing with a discontinuous contact layer surface has the advantages of promoting tissue growth with wound surface contact elements and permitting tissue growth by providing void volume for the subsequent tissue growth within the discontinuities. Desirably, the structure of the contact material is sufficiently physically rugged to resist flattening when forces required to press the material against the wound surface are applied to the material.

It is desirable for the material to retain its structure when exposed to aqueous or other bodily fluids. Many traditional dressing materials soften as then moisten so that their geometry changes. The contact layer is permeable, permitting the underlying wound to breathe and allowing for fluids to be drawn from the wound. The contact layer should not be too absorbent as this might result in a loss of structure. The layer is comprised of base materials that are resistant to change in the presence of moisture and aqueous liquids.

In the current embodiment, the extent of the voids remaining above the wound surface is preferably at least 0.1 mm when the structure is pressed against the surface of the wound. The width of the voids, as defined by contact elements adjacent the voids, is preferably greater than 0.1 mm. A more preferred width is between about 0.5 to 10 mm and a more preferred height is between about 0.2 to 5 mm.

Wound healing is recognized as a complex process. When a wound contact material as described is forced against a wound surface, a number of biological processes are believed to occur. Mechanical stress is applied to the underlying tissue. The discontinuities in the contact surface impose a force resulting in a catenary shape on the tissue. These mechanical forces encourage cellular activities as well as angiogenesis, and the discontinuities begin to fill with granular tissue. Excess fluid is conveyed away from the wound and tissue develops in a manner and pattern whereby disruption of the newly developed tissue is minimized upon removal of the contact surface.

A fibrous substrate or structure has all the flexibilities provided by the textile arts. Fibrous textiles can be formed into a structure for the invention by a number of the methods known in the art. Among these methods are knitting, weaving, embroidering, braiding, felting, spunbonding, meltblowing, and meltspinning. Each of these methods can be further adapted to produce a material whose structure matches that of the present invention. The desired structure can be imparted during production of the structure by, for example, applying molten material directly to a mold as in meltblowing. Alternatively, the structure can be formed by working a formed structure after production by, for example, heat stamping or vacuum forming. Further, fibers can be mixed with an adhesive and sprayed onto a textured surface.

The versatility of fibrous textiles also extends to their easy adaptation to composite applications. Individual fiber materials may be varied to optimize a physical parameter such as rigidity or flexibility. Individual fiber materials can also be selected for their known ability to assist in wound healing. Examples of such fiber materials are calcium alginate, and collagen. Alternatively, fibers may be treated with known wound healing agents such as hyaluronic acid and antimicrobial silver. The ratio of the fiber materials can be varied to suit the requirements of the wound. According to one desirable aspect of the invention, different fibers with various wound healing properties may be added as desired.

Other fibrous structures that are anticipated as beneficial additions include:

1. Fluid absorbing fibers

2. Non-adsorbent fibers

3. Bio-absorbable fibers

4. Wicking fibers to wick fluid away from the surface of the wound

5. Fibers with known healing effects, such as calcium alginate

6. Bio-erodable fibers for the controlled release of curative agent

7. Conductive fibers for the delivery of an electric charge or current

8. Adherent fibers for the selective removal of undesirable tissues, substances or microorganisms

9. Non-adherent fibers for the protection of delicate tissue

An exemplary embodiment of the present invention is illustrated in FIG. 1. As shown in FIG. 1, channeled wound dressing 100 is comprised of a generally conformable polyester felt material 102. An alternative polyester textile such as knit, weave, or braid may also be suitable for most applications. Polyolefins, such as polyethylene or polypropylene, and polyamides, such as nylon, with similar physical properties are also contemplated. Creep resistance, as exhibited by polyester, is particularly desirable. Void channels 104 are cut into felt material 102 to provide a discontinuity that promotes the upward growth of new tissue. In use, the channeled wound dressing 100 is pressed against a wound in intimate contact with injured tissue. A force of 0.1 psi or more is desirably applied to the contact layer to press the contact elements against the surface of the wound. Wound contact elements 106 are thus in intimate contact with injured tissue.

FIGS. 2A and 2B illustrate a wound dressing composite 200 comprised of channeled dressing 100 and a vapor permeable adhesive backed sheet 202. Adhesive backed vapor permeable sheets, in general, are known in the art and are believed to contribute to wound healing by maintaining a moisture level that is optimal for some wounds. In use, dressing composite 200 is placed onto the surface of the wound with its channeled dressing 100 portion in contact with the wound. Adhesive sheet 202 covers channeled dressing 100 and adheres to skin adjacent the wound. Composite 200 offers the advantages of channeled dressing 100. Additionally, adhesive sheet 202 secures composite 200 and protects the wound from bacteria, etc. while allowing for the transmission of moisture vapor.

Another desirable embodiment of the present invention is illustrated in FIGS. 3A, 3B and 3C and 3D. The substrate or structure for dimpled wound dressing 300 can be constructed from similar materials and production methods employed for channeled dressing 100. FIG. 3A depicts a perspective view of dimpled dressing 300 with contact surface 320 on top. FIG. 3D shows a cross section of the dimpled dressing 300 which best illustrates the plurality of contact elements 322 and dimple voids 330. Preferably, the total dimple void area comprises at least about 25% of the total dressing area. More preferably, the total dimple void area comprises at least about 50% of the total dressing area. Dimple voids 330 are partially defined by sidewalls 332. Sidewalls 332 are partially responsible for providing rigidity necessary to resist compaction of dimple dressing 300. Contact elements are preferably constructed to provide an arcuate contact surface. In a preferred embodiment, the radius of contact is between about 0.1 mm to 1 mm.

Dimple voids 330 can be formed in a variety of regular or irregular shapes. Preferably, dimple voids are constructed so that they are not "undercut" such that each aperture circumference is smaller than the corresponding inner void circumference. An "undercut" or reticulated void structure can cause tissue disruption when the dressing 300 is removed because any tissue that has grown into the void may be torn away when the material is removed from the wound. Additionally, undercut or reticulated void structures are more likely to result in shedding of the dressing material into the newly developing wound tissue.

In one preferred embodiment, a base material for dressing 300 is Masterflo.RTM. manufactured by BBA group of Wakefield, Mass. In this exemplary embodiment, the base material has a thickness of about 1.0 mm. Dimple voids 330 are heat stamped into the base material having a depth of about 0.75 mm and a diameter of about 2 mm.

Because the contact layer is generally replaced every few days it is important to account for the possibility of alignment of newly formed tissue with the voids of a new contact layer. Thus, according to exemplary embodiments of the present invention 1) dimple voids 300 can be arranged randomly so that they don't line up with the new tissue growth after each dressing change, 2) different contact layers with different diameter dimples may be provided, or 3) a different spacing of the dimples can be used every time the material is changed.

FIGS. 3B and 3C illustrate the corresponding top and bottom views, respectively, of dimpled dressing 300. One variation of this embodiment is also contemplated having dimple voids 330 and/or contact elements 322 disposed on both the top and bottom of dimpled dressing 300. A second variation on dimpled wound dressing 300 is also contemplated wherein some or all of the dimple voids 330 are replaced with holes traversing the structure's entire thickness such that the top and bottom views of the variation would appear similar to FIG. 3B.

In one exemplary embodiment, dimple voids 330 can be partially filled with therapeutic substances. For example, antiseptic substances might be placed in voids 330 for treating infected wounds. Further, biologic healing agents could be delivered in the voids to improve the rate of new tissue formation. In yet another exemplary embodiment, the layer of dressing 300 could have a different function on each side. For example, one side of dressing 300 could be optimized for the growth of new tissue, while the other side could be optimized for the delivery of anti-microbial agents, for example.

Use of dimpled dressing 300 is illustrated by FIGS. 4A, 4B and 4C. FIG. 4A shows a wound surface 400. Note that wound surface 400 may represent the majority of a shallow surface wound or a small interior portion of a deep tissue wound. FIG. 4B shows application of dimpled dressing 300 to wound surface 400 and corresponding tissue growth 410 within dimple voids 330. Finally, removal of dimpled dressing 300 leaving tissue growth 410 is illustrated in FIG. 4C. As will be addressed in detail below, it is desirable to provide an external force for keeping dressing 300 pressed against the surface of the wound.

FIGS. 5A and 5B illustrate another embodiment of the present invention; a rough irregular dressing 500. From a perspective view, FIG. 5A depicts how irregular dressing 500 has irregular voids 510 and irregular contact elements 520 acting as "hook-like" members that are able to contact and stick to necrotic tissue when the substrate is placed in the wound. When the substrate is removed from the wound, necrotic tissue is stuck to hook like protrusions 520 and is thus removed from the wound. Removal of the substrate debrides the wound. Removal of necrotic tissue is an important part of healing wounds. The substrate of dressing 500 may be made from polyester felt or batting. In one exemplary embodiment, the felt is singed with hot air so that a percentage of the fibers melt to form a textured surface with a number of hook like elements 520. Another suitable configuration can be the hook material such as that used with hook and loop fabric.

After adequate removal of the necrotic tissue, the wound may still be considered infected and can be treated with the substrate including antimicrobial silver, for example, which is useful in killing bacteria, while the substrate and method of use facilitate the growth of new tissue.

The phase of wound healing where new tissue is forming is generally referred to as the proliferative phase. Once the wound is adequately healed in the proliferative phase and the bacterial load is adequately reduced, a substrate without antimicrobial silver and optionally with the addition of growth enhancing materials is used to facilitate the continued proliferation of new cells and tissue.

FIG. 5B shows the random cross section of irregular dressing 500. The roughened surface of irregular dressing 500 can be formed by passing a suitable substrate under convective heat at or about the melting point of the substrate's component material. For example, polyester materials typically melt in a range from about 250 degrees Celsius to about 20 degrees Celsius. A polyester felt material passed briefly under a convective heat source operating in this range will experience surface melting and subsequent fusing of the polyester strands at its surface. The degree of surface melting can be controlled with temperature and exposure time to yield a surface of desired roughness exhibiting irregular voids 510 and irregular contact elements. Although irregular dressing 500 is illustrated as having only one roughened surface the invention is not so limited in that both upper and lower surfaces may be similarly roughened. Such a dressing would be useful in the treatment of an undermined wound.

As described above, treatment with the present wound dressing invention comprises forcing the inventive dressing into intimate contact with the wound surface. Generally the force should be at least 0.1 psi. Various methods and systems for maintaining this intimate contact are contemplated. These methods and systems may include: applying an adhesive film over the inventive dressing and adjacent the wound surface; wrapping a bandage over the dressing and around the injured area; and securing a balloon or another inflatable bladder to the structure and inflating the bladder with air or a liquid. In one exemplary embodiment, the application of pressure to the bladder is provided intermittently. A conformable seal may be placed over the wound and contact structure, a rigid seal is then secured over the wound, contact structure imparting a force on the contact structure. A pressure is then applied between the rigid seal and the flexible seal forcing the contact structure against the wound surface. The intimate contact may be augmented by sealing the wound area with a conformable cover and applying suction. When suction is used, dimpled wound dressing 300 is particularly well-adapted for this application. In general the range of suction levels is between 0.25 psi and 5 psi. The suction use can be further improved by applying a wound packaging material to the back of the dressing. One such suitable wound packaging material is described in U.S. Provisional Patent Application No. 60/554,158, filed on Mar. 18, 2004.

FIG. 6 illustrates therapeutic device 600 in use in wound W. As shown in FIG. 6, therapeutic device 600 with depressions 604, such as dimple void for example, is placed in wound W with depressions 604 placed adjacent wound surface 700. Wound W and therapeutic device 600 are desirably covered with wound cover 606, such as an adhesive back polyurethane film for example. In one exemplary embodiment, suction from a suction source (not shown) may be applied to wound W via suction tube 608 and coupling 610. As healing progresses, tissue 702 in the wound bed grows into depressions 604.

The depressions 604 remain intact even when the device is placed in a wound and suction is applied. Additionally, where the material of the device is comprised of generally non-absorbent fibers, the material does not get soggy when in a wet wound. This allows the wound fluids to be pulled out of the wound by suction, for example, and additionally ensures that depressions 604 remain. It is critical that the depressions remain, so that voids exist where new tissue can grow filling the wound cavity.

While the above described configuration uses depressions having a dimpled shape, other 3 dimensional structures can be fabricated such that there is a void for tissue to grow in to. One such non-limiting alternative configuration would be a woven waffle pattern.

Case Study 1

Patient A is a 70 year old male with a Stage IV decubitus ulcer on the right hip with significant undermining. The contact structure of the present invention was applied to the wound and an adhesive film was placed over the wound and the contact structure. A suction of 1.1 psi was applied beneath the adhesive film to impart a force upon the contact structure. The suction was maintained generally continuously. The contact material was replaced every two to four days. After use of the device for 30 days the undermined portion of the wound had virtually healed and the area of the wound opening had decreased from 66 square cm to 45 square cm. A split thickness skin graft was applied to the wound.

Case Study 2

Patient B is a 50 year old male with a fracture of the right ankle with exposed bone. A plate was used to reduce the fracture and a rectus abdominus free flap was performed to cover the exposed bone and hardware. The flap only partially survived resulting in an open wound with exposed bone and hardware. The contact structure of the present invention was applied to the wound and an adhesive film was placed over the wound and the contact structure. A force was applied to the contact structure by the application of an ace bandage wrapped around the ankle or by the application of suction. The suction force was generally applied for about half of the day and the force of the bandage wrap was maintained for the remainder of the day. For a number of days, the bandage wrap was solely used to impart the force. When the force was imparted by suction a suction of between 1 and 2 psi was used. In less than 2 weeks new tissue had grown over the exposed hardware. In a period of 7 weeks the wound area was reduced from 50 square cm to 28 square cm.

While preferred embodiments of the invention have been shown and described herein, it will be understood that such embodiments are provided by way of example only. Numerous variations, changes, and substitutions will occur to those skilled in the art without departing from the spirit of the invention. Accordingly, it is intended that the appended claims cover all such variations as fall within the spirit and scope of the invention.

* * * * *

2014, Патинформбюро. Русификация заголовков и переформатирование исходного htm-описания патентов: В.И. Карнышев

Патент США №

Автор(ы)

Дата выдачи

Method of manufacturing a dressing

РЕФЕРАТ

Авторы:

Заявитель:

ID семейства патентов

Номер заявки:

Дата регистрации:

Отсылочные патентные документы США

Класс патентной классификации США:

Класс совместной патентной классификации:

Класс международной патентной классификации (МПК):

Область поиска: